Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer's Disease”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00675623
What this trial is testing

A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Medivation, Inc. 598
Testing effectiveness (Phase 2)UnknownNCT03806478
What this trial is testing

Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
DementiaAlzheimer Disease 1Alzheimer Disease 2+1 more
Aphios 60
Testing effectiveness (Phase 2)Study completedNCT01078168
What this trial is testing

Alzheimer's Disease Acitretin Medication

Who this might be right for
Alzheimer Disease
K. Lieb 22
Testing effectiveness (Phase 2)Study completedNCT03507790
What this trial is testing

Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

Who this might be right for
Mild to Moderate Alzheimer's Disease
Cognition Therapeutics 153
Not applicableUnknownNCT04938271
What this trial is testing

A Telehealth Study of a Wearable Electroceutical & Sports Sleeve for Knee Osteoarthritis Pain Relief & Improved Function

Who this might be right for
Osteoarthritis, Knee
Healables Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03605667
What this trial is testing

Study of BHV-4157 in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Biohaven Pharmaceuticals, Inc. 350
Testing effectiveness (Phase 2)WithdrawnNCT01066481
What this trial is testing

Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementiaDimebon+1 more
Pfizer
Large-scale testing (Phase 3)Study completedNCT00277810
What this trial is testing

Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 250
Early research (Phase 1)Study completedNCT02640092
What this trial is testing

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 72
Post-approval studies (Phase 4)Study completedNCT02703636
What this trial is testing

NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.

Who this might be right for
Mild to Moderate Alzheimer's Disease
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Study completedNCT04735536
What this trial is testing

Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG

Who this might be right for
Alzheimer Disease
Cognition Therapeutics 16
Early research (Phase 1)Ended earlyNCT01028911
What this trial is testing

Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 9
Large-scale testing (Phase 3)Study completedNCT01872598
What this trial is testing

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
AB Science 721
Large-scale testing (Phase 3)Study completedNCT00645190
What this trial is testing

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Xian-Janssen Pharmaceutical Ltd. 215
Post-approval studies (Phase 4)Study completedNCT01122329
What this trial is testing

A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
University of California, Los Angeles 17
Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Testing effectiveness (Phase 2)Study completedNCT01397578
What this trial is testing

Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 91
Post-approval studies (Phase 4)Study completedNCT00035204
What this trial is testing

The Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 63
Early research (Phase 1)Study completedNCT01716637
What this trial is testing

Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Life Extension Foundation Inc. 12
Post-approval studies (Phase 4)Study completedNCT00505167
What this trial is testing

Memantine Versus Donepezil in Early Stages of Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
Hospital Miguel Servet 64
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation